Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Foundation Medicine, Inc. (FMI) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2018 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of the Company (filed herewith)",
"Bylaws of the Company (filed herewith)"
06/21/2018 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : June 21, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commenceme..."
06/19/2018 8-K Quarterly results
06/07/2018 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : June 6, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable"
05/02/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : May 2, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement...",
"Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights"
03/19/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : March 16, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencem...",
"Foundation Medicine Announces Final National Coverage Determination from the Centers for Medicare & Medicaid Services , Including Coverage for FoundationOne CDx™ Across All Solid Tumors"
03/07/2018 8-K Quarterly results
Docs: "Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook"
03/05/2018 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : February 28, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable"
01/08/2018 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Foundation Medicine Reports Preliminary 2017 Results",
"Presentation Slide Deck, furnished hereto"
12/19/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Q"
12/01/2017 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics"
11/01/2017 8-K Quarterly results
Docs: "Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights"
10/10/2017 8-K Quarterly results
09/13/2017 8-K Quarterly results
06/21/2017 8-K Form 8-K - Current report
05/09/2017 8-K Form 8-K - Current report
04/12/2017 8-K Form 8-K - Current report
03/02/2017 8-K Form 8-K - Current report
02/22/2017 8-K Form 8-K - Current report
01/09/2017 8-K Form 8-K - Current report
01/06/2017 8-K Form 8-K - Current report
12/20/2016 8-K Form 8-K - Current report
11/02/2016 8-K Form 8-K - Current report
10/28/2016 8-K Form 8-K - Current report
10/05/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Third Amendment to Lease, by and between Foundation Medicine, Inc., as tenant and ARE-MA Region No. 50, LLC, as landlord",
"Consent to Assignment, by and among ARE-MA Region No. 50, LLC, bluebird bio, Inc., and Foundation Medicine, Inc.",
"Assignment and Assumption of Lease, by and between Foundation Medicine, Inc. and bluebird bio, Inc."
08/02/2016 8-K Form 8-K - Current report
06/22/2016 8-K Submission of Matters to a Vote of Security Holders
05/03/2016 8-K Form 8-K - Current report
04/12/2016 8-K Form 8-K - Current report
03/28/2016 8-K Form 8-K - Current report
02/23/2016 8-K Quarterly results
Docs: "Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook"
01/11/2016 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Foundation Medicine Reports Preliminary 2015 Results and Provides 2016 Business Outlook, including Commercial Launch of its ctDNA Assay",
"Presentation Slide Deck"
11/03/2015 8-K Quarterly results
Docs: "Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights Year-over-Year Third Quarter Revenues Grow 54%; FoundationCORE™ Expands to Approximately 60,000 Patient Cases; ctDNA Product Launch on Track"
08/21/2015 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Collaboration Agreement, by and among the Company, F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc.",
"Ex-US Commercialization Agreement, by and between the Company and F. Hoffmann-La Roche Ltd",
"US Education Collaboration Agreement, by and between the Company and Genentech, Inc.",
"Binding Term Sheet for an In Vitro Diagnostics Collaboration, by and between the Company and F. Hoffman-La Roche Ltd"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy